# Safety and Efficacy of Gabapentin in Postherpetic Neuralgia

> **NCT00636636** · PHASE3 · COMPLETED · sponsor: **Depomed** · enrollment: 452 (actual)

## Conditions studied

- Neuralgia,Postherpetic

## Interventions

- **DRUG:** Gabapentin Extended Release tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00636636
- **Lead sponsor:** Depomed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-08
- **Final completion:** 2009-09
- **Target enrollment:** 452 (ACTUAL)
- **Last updated:** 2012-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00636636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00636636, "Safety and Efficacy of Gabapentin in Postherpetic Neuralgia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00636636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*